Abstract
Objectives
The study was to develop a Gd-EOB-DTPA-enhanced MRI radiomics model for preoperative prediction of VETC and patient prognosis in hepatocellular cancer (HCC).
Methods
The study included 182 (training cohort: 128; validation cohort: 54) HCC patients who underwent preoperative Gd-EOB-DTPA-enhanced MRI. Volumes of interest including intratumoral and peritumoral regions were manually delineated in the hepatobiliary phase images, from which 1316 radiomics features were extracted. The least absolute shrinkage and selection operator (LASSO) and multivariable logistic regression were used to select the useful features. Clinical, intratumoral, peritumoral, combined radiomics, and clinical radiomics models were established using machine learning algorithms. The Kaplan–Meier survival analysis was used to assess early recurrence and progression-free survival (PFS) in the VETC + and VETC- patients.
Results
In the validation cohort, the area under the curves (AUCs) of radiomics models were higher than that of the clinical model using random forest (all p < 0.05). The peritumoral radiomics model (AUC = 0.972;95% confidence interval [CI]:0.887–0.998) had significantly higher AUC than intratumoral model (AUC = 0.919; 95% CI: 0.811–0.976) (p = 0.044). There were no significant differences in AUC between intratumoral or peritumoral radiomics model (PR) and combined radiomics model (p > 0.05). Early recurrence and PFS were significantly different between the PR-predicted VETC + and VETC- HCC patients (p < 0.05). PR-predicted VETC was independent predictor of early recurrence (hazard ratio [HR]: 2.08[1.31–3.28]; p = 0.002) and PFS (HR: 1.95[1.20–3.17]; p = 0.007).
Conclusions
The intratumoral or peritumoral radiomics model may be useful in predicting VETC and patient prognosis preoperatively. The peritumoral radiomics model may yield an incremental value over intratumoral model.
Key Points
• Radiomics models are useful for predicting vessels encapsulating tumor clusters (VETC) and patient prognosis preoperatively.
• Peritumoral radiomics model may yield an incremental value over intratumoral model in prediction of VETC.
• Peritumoral radiomics-model-predicted VETC was an independent predictor of early recurrence and progression-free survival.
Similar content being viewed by others
Abbreviations
- 3D VIBE:
-
Three-dimensional volume interpolated breath-hold examination
- AFP:
-
Alpha-fetoprotein
- ALT:
-
Alanine aminotransferase
- AST:
-
Aspartate aminotransferase
- AUC:
-
Area under the receiver operating characteristic curve
- CI:
-
Confidence interval
- Gd-EOB-DTPA:
-
Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid
- Glcm:
-
Gray level co-occurrence matrix
- Gldm:
-
Gray level dependence matrix
- Glrlm:
-
Gray level run length matrix
- Glszm:
-
Gray level size zone matrix
- HCC:
-
Hepatocellular carcinoma
- HR:
-
Hazard ratio
- ICC:
-
Intra-class correlation coefficient
- IQR:
-
Interquartile range
- LASSO:
-
Least absolute shrinkage and selection operator
- LoG:
-
Laplacian of gaussian
- MVI:
-
Microvascular invasion
- Ngtdm:
-
Neighboring gray tone difference matrix
- PFS:
-
Progression-free survival
- PR:
-
Peritumoral radiomics model
- SVM:
-
Support vector machine
- VETC:
-
Vessels encapsulating tumor clusters
- VOI:
-
Volume of interest
References
Xu X, Zhang HL, Liu QP et al (2019) Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma. J Hepatol 70:1133–1144
Huang X, Long L, Wei J et al (2019) Radiomics for diagnosis of dual-phenotype hepatocellular carcinoma using Gd-EOB-DTPA-enhanced MRI and patient prognosis. J Cancer Res Clin Oncol 145:2995–3003
Ma X, Wei J, Gu D et al (2019) Preoperative radiomics nomogram for microvascular invasion prediction in hepatocellular carcinoma using contrast-enhanced CT. Eur Radiol 29:3595–3605
Renne SL, Woo HY, Allegra S et al (2020) Vessels encapsulating tumor clusters (VETC) is a powerful predictor of aggressive hepatocellular carcinoma. Hepatology 71:183–195
Fang JH, Zhou HC, Zhang C et al (2015) A novel vascular pattern promotes metastasis of hepatocellular carcinoma in an epithelial-mesenchymal transition-independent manner. Hepatology 62:452–465
Fang JH, Xu L, Shang LR et al (2019) Vessels that encapsulate tumor clusters (VETC) pattern is a predictor of sorafenib benefit in patients with hepatocellular carcinoma. Hepatology 70:824–839
Chen S, Feng S, Wei J et al (2019) Pretreatment prediction of immunoscore in hepatocellular cancer: a radiomics-based clinical model based on Gd-EOB-DTPA-enhanced MRI imaging. Eur Radiol 29:4177–4187
Chen Y, Qin X, Long L et al (2020) Diagnostic value of Gd-EOB-DTPA-enhanced MRI for the expression of Ki67 and microvascular density in hepatocellular carcinoma. J Magn Reson Imaging 51:1755–1763
Wu M, Tan H, Gao F et al (2019) Predicting the grade of hepatocellular carcinoma based on non-contrast-enhanced MRI radiomics signature. Eur Radiol 29:2802–2811
Lee S, Kim SH, Lee JE, Sinn DH, Park CK (2017) Preoperative gadoxetic acid-enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinoma. J Hepatol 67:526–534
Wu J, Liu A, Cui J, Chen A, Song Q, Xie L (2019) Radiomics-based classification of hepatocellular carcinoma and hepatic haemangioma on precontrast magnetic resonance images. BMC Med Imaging 19:23
Shan QY, Hu HT, Feng ST et al (2019) CT-based peritumoral radiomics signatures to predict early recurrence in hepatocellular carcinoma after curative tumor resection or ablation. Cancer Imaging 19:11
Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: images are more than pictures, they are data. Radiology 278:563–577
Dou TH, Coroller TP, van Griethuysen JJM, Mak RH, Aerts HJWL (2018) Peritumoral radiomics features predict distant metastasis in locally advanced NSCLC. PLoS One 13:e0206108
Feng ST, Jia Y, Liao B et al (2019) Preoperative prediction of microvascular invasion in hepatocellular cancer: a radiomics model using Gd-EOB-DTPA-enhanced MRI. Eur Radiol 29:4648–4659
Roayaie S, Blume IN, Thung SN et al (2009) A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. Gastroenterology 137:850–855
Kim S, Shin J, Kim DY, Choi GH, Kim MJ, Choi JY (2019) Radiomics on gadoxetic acid-enhanced magnetic resonance imaging for prediction of postoperative early and late recurrence of single hepatocellular carcinoma. Clin Cancer Res 25:3847–3855
Acknowledgements
This work was supported by the National Natural Science Foundation of China (81801692) and Suzhou Municipal Science and Technology Bureauand (SYS2020125, SS2019057, SS201808).
Funding
This study has received funding from the National Natural Science Foundation of China (81801692) and Suzhou Municipal Science and Technology Bureauand (SYS2020125, SS2019057, SS201808).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Guarantor
The scientific guarantor of this publication is Chunhong Hu.
Conflict of interest
The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.
Statistics and biometry
Ximing Wang kindly provided statistical advice for this manuscript.
Informed consent
Written informed consent was waived by the Institutional Review Board.
Ethical approval
Institutional Review Board approval was obtained.
Methodology
• retrospective
• diagnostic or prognostic study
• performed at one institution
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Yu, Y., Fan, Y., Wang, X. et al. Gd-EOB-DTPA-enhanced MRI radiomics to predict vessels encapsulating tumor clusters (VETC) and patient prognosis in hepatocellular carcinoma. Eur Radiol 32, 959–970 (2022). https://doi.org/10.1007/s00330-021-08250-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-021-08250-9